ArticleOncotarget2017

Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus.

Chin-Hsiao TsengPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.